Hester Biosciences Ltd - 524669 - Shareholder Meeting / Postal Ballot-Notice of Postal Ballot
Hester Biosciences announced a Postal Ballot to reclassify two promoters, Mr. Ravin Gandhi and Ms. Bela Gandhi, as public shareholders. This move, concerning their 4.74% and 4.71% stakes respectively, aims to comply with SEBI regulations and potentially enhance public float.
Aug 04 2026 19:23:18
Hester Biosciences Ltd - 524669 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Hester Biosciences held its Q1 FY27 earnings call, highlighting robust standalone performance with 14% revenue growth and 88% PAT increase. The company also announced a significant restructuring of a $12 million loan for its Hester Africa unit, making it interest-free.
Aug 01 2026 14:15:48
Hester Biosciences Ltd - 524669 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Hester Biosciences announced the availability of the audio recording for its Q1 FY27 earnings conference call. Investors can access the recording via the company's website.
Jul 30 2026 16:46:54
Hester Biosciences Ltd - 524669 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Hester Biosciences reported strong Q1 FY27 standalone results with revenue up 14% and net profit up 88%. Consolidated profit surged 459% due to a significant exceptional gain from a loan amendment.
Jul 30 2026 11:35:00
Hester Biosciences Ltd - 524669 - Board Meeting Outcome for Outcome Of Board Meeting Held On 30 July 2026
Hester Biosciences' Q1 FY27 standalone revenue rose 14% YoY to ₹72.66 crore, with PAT up 88% to ₹14.71 crore. Consolidated PAT soared 459% YoY to ₹96.73 crore, primarily due to an ₹85.35 crore exceptional gain from a loan amendment with the Gates Foundation for its Africa subsidiary.
Jul 30 2026 11:16:40
Hester Biosciences Ltd - 524669 - Board Meeting Intimation for Financial Results
Hester Biosciences board will convene on July 30, 2026, to consider and approve the financial results for Q1 FY27. This meeting will review both standalone and consolidated performance.
Jul 23 2026 16:26:50
Hester Biosciences Ltd - 524669 - Disclosure Under Regulation 30 Of The SEBI Listing Regulations- Sale Of Equity Investment In Texas Lifesciences Private Limited
Hester Biosciences Ltd divested its entire 11% equity stake in Texas Lifesciences Private Limited on July 8, 2026, for INR 23 million. This transaction reduces the company's shareholding in TLPL to nil.
Jul 09 2026 16:34:49
Read More